Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Meditation therapies for attention-deficit/hyperactivity disorder (ADHD)
    Cochrane Systematic Reviews, 11-May-2010
  • Meditation therapy for anxiety disorders
    Cochrane Systematic Reviews, 10-Nov-2008
  • Megestrol acetate for treatment of anorexia‐cachexia syndrome
    Cochrane Systematic Reviews, 28-Mar-2013
  • Melatonin for the treatment of dementia
    Cochrane Systematic Reviews, 16-Feb-2011
  • Memantine for dementia
    Cochrane Systematic Reviews, 20-Mar-2019
  • Mentoring adolescents to prevent drug and alcohol use
    Cochrane Systematic Reviews, 5-Sep-2011
  • Metal protein attenuating compounds for the treatment of Alzheimer's dementia
    Cochrane Systematic Reviews, 20-Feb-2014
  • Methadone at tapered doses for the management of opioid withdrawal
    Cochrane Systematic Reviews, 28-Feb-2013
  • Methadone for cancer pain
    Cochrane Systematic Reviews, 8-Feb-2017
  • Methadone maintenance at different dosages for opioid dependence
    Cochrane Systematic Reviews, 25-Mar-2008
  • Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
    Cochrane Systematic Reviews, 8-Jul-2009
  • Metrifonate for Alzheimer's disease
    Cochrane Systematic Reviews, 18-Mar-2008
  • Milnacipran versus other antidepressive agents for depression
    Cochrane Systematic Reviews, 8-Jul-2009
  • Mind‐body interventions during pregnancy for preventing or treating women's anxiety
    Cochrane Systematic Reviews, 6-Jul-2011
  • Mirtazapine versus other antidepressive agents for depression
    Cochrane Systematic Reviews, 9-Nov-2011
  • Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia
    Cochrane Systematic Reviews, 19-Mar-2018
  • Mobile phone text messaging and app‐based interventions for smoking cessation
    Cochrane Systematic Reviews, 22-Oct-2019
  • Molindone for schizophrenia and severe mental illness
    Cochrane Systematic Reviews, 13-May-2008
  • Monetary incentives for schizophrenia
    Cochrane Systematic Reviews, 7-Oct-2009
  • Morita therapy for schizophrenia
    Cochrane Systematic Reviews, 25-Jul-2012
[x]

Login or Subscribe

Login

Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More